Max Planck Institute for Innovation and Competition (Munich)

Giulio Matarazzi

Max Planck Institute for Innovation and Competition (Munich)
Doctoral Student and Junior Research Fellow

Giulio Matarazzi is Doctoral Student and Junior Research Fellow in Intellectual Property and Competition Law at the Max Planck Institute for Innovation and Competition, Munich. Previously, he was an associate at BonelliErede. He graduated cum laude from the Rome L.U.I.S.S. Guido Carli University in 2013, with a dissertation on EU Antitrust Law.

Linked authors

Africa University (Mutare)
Max Planck Institute for Innovation and Competition (Heidelberg)
GRUR International (Munich)
European University Institute (Florence)
Max Planck Institute for Innovation and Competition (Munich)

Articles

4457 Bulletin

Giulio Matarazzi, Sara Lembo The Italian Competition Authority fines undertakings for an anticompetitive agreement concerning the assignment of broadcasting rights to Italian football league matches (Vendita diritti televisivi Serie A 2015-2018)

574

In its decision of 19 April 2016, the Italian Competition Authority (“ICA”) imposed fines totalling EUR 66 million on Sky and Mediaset, the main television operators in the pay-tv market, and on the Italian Football League (“Lega Calcio”) and its advisor Infront, for breach of Article 101 of (...)

Giulio Matarazzi, Sara Lembo The Italian Council of State refers to the EU Court of Justice for a preliminary ruling in a case regarding an agreement to artificially differentiate competing drugs (Roche / Novartis)

401

By its decision of 11 March 2016 , the Italian Administrative Court of Last Instance (“Council of State”) referred to the European Court of Justice certain preliminary questions raised by Novartis and Roche in the appeals brought against the judgment of the Administrative Court of First (...)

Giulio Matarazzi, Sara Lembo The Italian Competition Authority opens an investigation into the tender procedures for oxygen-therapy and ventilo-therapy services at home (Gare ossigenoterapia e ventilopterapia)

280

With a decision of 7 October 2015, following the complaints lodged by one of the local health units in the city of Milan (“ASL Milan”) and the purchasing consortium of the Campania Region (“Soresa”), the Italian Competition Authority (“ICA”) opened an investigation into 14 companies (...)

Giulio Matarazzi, Sara Lembo The Italian Competition Authority accepts commitments to amend a co-marketing agreement in the pharmaceutical sector, and closes its antitrust investigation (Novartis / Italfarmaco)

472

With Decision No. 25508 of 4 June 2015, the Italian Competition Authority (the “ICA”), accepted the commitments proposed by Novartis Farma S.p.A. (“Novartis”) and Italfarmaco S.p.A. (“Italfarmaco”, together the “Parties”) and closed the investigation opened following a complaint lodged by the (...)

Giulio Matarazzi, Sara Lembo The Italian Competition Authority opens a Phase II proceedings on the hostile takeover bid of a transmission tower provider (EI Towers / Rai Way)

223

In its decision of 10 March 2015, the Italian Competition Authority (the “ICA” or the “Authority”) decided to open Phase II proceedings in relation to the merger notified on 25 February consisting of EI Towers S.p.A.’s (“EI Towers”) hostile takeover bid over 100% of Rai Way S.p.A.’s (“Rai Way” (...)

Giulio Matarazzi, Sara Lembo The Italian Council of State confirms the Competition Authority’s decision adopted in an abuse of dominance case in the mass retail sector (Coop Estense / AGCM)

216

In its decision of 8 April 2014 the Italian Administrative Court of Last Instance (“Council of State”) overruled the previous decision of the Administrative Court of First Instance (“TAR Lazio”) and confirmed the legitimacy of the decision of the Italian Competition Authority (“ICA”) , which (...)

Giulio Matarazzi, Sara Lembo The Italian Competition Authority fines a pharmaceutical company for having “artificially differentiated” their medicinal products in breach of Article 101 TFEU (Roche-Novartis/Farmaci Avastin e Lucentis)

286

In its decision of 27 February 2014, the Italian Competition Authority (the “ICA” or the “Authority”), following the complaints lodged by the Italian Ophthalmological Society (“SOI” - Società oftalmologica italiana) and an association of private healthcare hospitals (“AIUDAPDS” - Associazione (...)

Books

Statistics


4457
Total visits

405.2
Number of readings per contribution

11
Number of contributions

Author's ranking
905th
In number of contributions
1883th
In number of visits
4523th
In average number of visits
Send a message